Given that TNF-α synergizes with IL-23 to promote IL-17A production by ILCs (54), it is likely that TNF-α and IL-23 inhibition are effective for psoriasis at least in part due to their ILC3 suppressive effects, thereby reducing IL-17A. Here, TNF is linked to psoriasis.